Does DARATUMUMAB Cause Polyneuropathy? 424 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 424 reports of Polyneuropathy have been filed in association with DARATUMUMAB (DARZALEX). This represents 1.6% of all adverse event reports for DARATUMUMAB.
424
Reports of Polyneuropathy with DARATUMUMAB
1.6%
of all DARATUMUMAB reports
20
Deaths
36
Hospitalizations
How Dangerous Is Polyneuropathy From DARATUMUMAB?
Of the 424 reports, 20 (4.7%) resulted in death, 36 (8.5%) required hospitalization, and 4 (0.9%) were considered life-threatening.
Is Polyneuropathy Listed in the Official Label?
Yes, Polyneuropathy is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Polyneuropathy?
DEXAMETHASONE (953)
BORTEZOMIB (890)
PACLITAXEL (741)
OXALIPLATIN (691)
CYCLOPHOSPHAMIDE (686)
FLUOROURACIL (525)
TRASTUZUMAB (478)
CARBOPLATIN (463)
DOXORUBICIN (452)
VINCRISTINE (440)
Which DARATUMUMAB Alternatives Have Lower Polyneuropathy Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE